CD28 Costimulatory Domain–Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function

Abstract
CD28 mutations enhance CAR T-cell function by reducing expression of transcription factors such as NFAT and NUR77, which in turn reduce expression of exhaustion-related genes. These data highlight considerations for CAR design that could improve antitumor responses.
Funding Information
  • NCI (P30-CA076292)
  • Moffitt Cancer Center (P30-CA076292)

This publication has 41 references indexed in Scilit: